Artelo Biosciences, Inc. (ARTL): Shareholders' Equity
-$1.27M
As of 2025-12-31
$5.00M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.27M | n/m | 2026-02-24, Balance as of period end |
| 2024-12-31 | $2.86M | -75.7% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $11.75M | -39.4% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $19.40M | -28.6% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $27.17M | n/a | 2023-03-31, Balance as of period end |
| 2021-08-31 | $12.04M | +210.8% | 2023-03-31, Balance as of period end |
| 2020-08-31 | $3.88M | -29.0% | 2021-11-29, Balance as of period end |
| 2019-08-31 | $5.46M | n/m | 2020-11-04, Balance as of period end |
| 2018-08-31 | -$135.0K | n/m | 2019-12-18, Balance as of period end |
| 2017-08-31 | $544.8K | n/m | 2018-11-29, Balance as of period end |
| 2016-08-31 | -$13.8K | n/c | 2017-11-29, Balance as of period end |
| 2015-08-31 | $15.3K | +3.8% | 2016-11-29, Balance as of period end |
| 2014-08-31 | $14.7K | n/a | 2015-12-11, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$1.27M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$17.51M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.83M | -34.5% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.15M | +4.4% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$2.49M | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $1.08M | -92.0% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $2.67M | n/m |
Compare ARTL, BFRG, NTHI, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗